10x Genomics Shares Outstanding 2018-2026 | TXG
10x Genomics shares outstanding history from 2018 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- 10x Genomics shares outstanding for the quarter ending June 30, 2026 were 0.130B, a 4.4% increase year-over-year.
- 10x Genomics 2025 shares outstanding were 0.125B, a 3.57% increase from 2024.
- 10x Genomics 2024 shares outstanding were 0.12B, a 2.81% increase from 2023.
- 10x Genomics 2023 shares outstanding were 0.117B, a 2.9% increase from 2022.
|
10x Genomics Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 125 |
| 2024 | 120 |
| 2023 | 117 |
| 2022 | 114 |
| 2021 | 110 |
| 2020 | 101 |
| 2019 | 39 |
| 2018 | 13 |
| 2017 | 12 |
|
10x Genomics Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-06-30 | 130 |
| 2026-03-31 | 128 |
| 2025-12-31 | 125 |
| 2025-09-30 | 126 |
| 2025-06-30 | 125 |
| 2025-03-31 | 123 |
| 2024-12-31 | 120 |
| 2024-09-30 | 121 |
| 2024-06-30 | 120 |
| 2024-03-31 | 119 |
| 2023-12-31 | 117 |
| 2023-09-30 | 118 |
| 2023-06-30 | 117 |
| 2023-03-31 | 116 |
| 2022-12-31 | 114 |
| 2022-09-30 | 114 |
| 2022-06-30 | 114 |
| 2022-03-31 | 113 |
| 2021-12-31 | 110 |
| 2021-09-30 | 111 |
| 2021-06-30 | 110 |
| 2021-03-31 | 109 |
| 2020-12-31 | 101 |
| 2020-09-30 | 101 |
| 2020-06-30 | 99 |
| 2020-03-31 | 97 |
| 2019-12-31 | 96 |
| 2019-09-30 | 29 |
| 2019-06-30 | 16 |
| 2019-03-31 | 15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $9.135B | $0.643B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |